Vassili Glazyrine, MD
Urology · Nashua, NHNPI 1063079309
Payments from drug & device makers
What this record shows
Boston Scientific accounts for 68.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $1,665 and has fallen 58.7% since, to $688 in 2025.
Across 56 payments — averaging $54.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Teleflex LLC$346
- Endo USA, Inc.$100
- Medtronic$86
- Blue Earth Diagnostics$61
- Antares Pharma, Inc.$58
- plus $305 from 10 others
What the payments were for
- Travel & lodging$1,35544%
- Food & beverage$1,71656%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $2,115 |
| Teleflex LLC | 8 | $346 |
| Endo USA, Inc. | 4 | $100 |
| Medtronic | 4 | $86 |
| Blue Earth Diagnostics | 2 | $61 |
| Antares Pharma, Inc. | 2 | $58 |
| Procept Biorobotics Corporation | 2 | $46 |
| Tolmar, Inc. | 2 | $44 |
| Myriad Genetic Laboratories, Inc. | 2 | $43 |
| Intuitive Surgical | 1 | $33 |
| AbbVie | 1 | $29 |
| Progenics Pharmaceuticals, Inc. | 1 | $28 |
| Urogen Pharma, Inc. | 1 | $23 |
| Calyxo, Inc. | 1 | $23 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS 700 CXR RTE KIT$1,268
- AdVance XP$143
- Barrigel$129
- UroLift$113
How this compares
$3,071 in reported general payments places this provider in the 75th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 79 | $1,076 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $546 |
| Finasteride | 38 | $545 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $77 |
| Ciprofloxacin Hcl | 31 | $70 |
| Oxycodone Hcl | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other urology in Nashua
- Matthew JohnsonNashua$6K
- Miguel AnteloNashua$4K
- Stephen HillNashua$1K
- Gary DunetzNashua$666
- Matthew StanizziNashua$79
- Martin GrossKeene$172K
- Ramiro Madden-FuentesConcord$82K
- Jason AkermanManchester$53K
- Lori LernerLebanon$49K
- E William JohnsonExeter$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.